Vivus Obesity Drug Market Is Very Large, Tam Says
July 18 (Bloomberg) -- Peter Tam, president of Vivus Inc., talks about the Food and Drug Administration's approval of its obesity drug Qsymia.
He speaks with Adam Johnson on Bloomberg Television's "Street Smart." Barry Ritholtz, chief executive officer of FusionIQ, also speaks. (Source: Bloomberg)